← Leaderboards
Jonathan J Kotzin
University Of Pennsylvania
$126,872
Attributed
$126,872
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $88.4K · FY2017–25$100K$75K$50K$25K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$126,872 · 2
By mechanism
F32$88,360 · 1
F30$38,512 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Meenhard Herlyn$50,214,821
- Klaus H. Kaestner$80,959,526
- Daniel James Rader$77,348,993
- Mitchell A. Lazar$48,884,193
- Mark L Kahn$46,704,160
Others in their field
Other Emerging Leaders on “Regulation”
- Martha Hering · Westat, Inc.$57,098,843
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$45,777,083
- Carina Remgsamai-Nhe · Fisher Bioservices, Inc.$44,034,909
- Leonard Freedman · Leidos Biomedical Research, Inc.$35,751,484
- Michelle Lynn Sever · Rho Federal Systems Division, Inc.$26,732,375
- Eric C Palm · Florida State University$26,502,247
Research focus
RegulationCellsInsightResponseImmunityCell SurvivalDefectImpairmentPhenotypeSignal TransductionPathway InteractionsIn VivoApoptoticImmuneB-Cell ActivationAutoreactivityAutoimmunityAutoimmune DiseasesApoptosisAntibodiesCardiovascular DiseasesB-Lymphocyte SubsetsCd95 AntigensAutoantigens